FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market – The Economic Times

Share

Share

Share

Share

Email

Comments

1. FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market  The Economic Times
2. How Wockhardt created India’s first fully homegrown drug  Forbes India
3. Wockhardt opts for self-commercialisation of Zaynich over licensing to maximise value: Chairman  Moneycontrol.com
4. Wockhardt marks research milestone with USFDA approval for novel antibiotic Zaynich  BusinessLine
5. CDSCO grants marketing authorisation to Wockhardt’s drug ZAYNICH® for treatment of complicated UTIs  BioSpectrum India